Advertisement

Ads Placeholder
Loading...

Cerus Corporation

CERS•NASDAQ
Healthcare
Medical - Devices
$1.86
$-0.01(-0.53%)
U.S. Market opens in 20h 16m

Cerus Corporation (CERS) Stock Overview

Explore Cerus Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap357.4M
P/E Ratio-22.69
EPS (TTM)$-0.08
ROE-0.26%
Fundamental Analysis

AI Price Forecasts

1 Month$2.05
3 Months$2.69
1 Year Target$1.88

CERS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cerus Corporation (CERS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 46.06, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.88.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -22.69 and a market capitalization of 357.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.53%
5-Day Change
2.76%
1-Month Change
-12.68%
3-Month Change
-5.58%
6-Month Change
18.47%
Year-to-Date (YTD) Change
-5.58%
1-Year Change
44.19%
3-Year Change
-34.97%
5-Year Change
-68.74%
All-Time (Max) Change
-84.66%

Contact Information

https://www.cerus.com
925 288 6000
1220 Concord Avenue, Concord, CA, 94520

Company Facts

6,140 Employees
IPO DateJan 31, 1997
CountryUS
Actively Trading

Frequently Asked Questions